(Bloomberg) -- Boston doctor Annaswamy Raji says she
was so alarmed by a study linking GlaxoSmithKline Plc's drug
Avandia to heart disease that she immediately advised a diabetes
patient to stop taking the medicine.
Research released May 21 by the New England Journal of
Medicine provided evidence that Avandia raises the chance of a
heart attack by as much as 43 percent. London-based Glaxo shares
dropped for a third day, bringing the week's decline to 7.5
percent. The data caused U.S. lawmakers to question the
government's drug-safety monitoring.
Read more at Bloomberg Exclusive News
was so alarmed by a study linking GlaxoSmithKline Plc's drug
Avandia to heart disease that she immediately advised a diabetes
patient to stop taking the medicine.
Research released May 21 by the New England Journal of
Medicine provided evidence that Avandia raises the chance of a
heart attack by as much as 43 percent. London-based Glaxo shares
dropped for a third day, bringing the week's decline to 7.5
percent. The data caused U.S. lawmakers to question the
government's drug-safety monitoring.
Read more at Bloomberg Exclusive News
No comments:
Post a Comment